Gainesville, FL, United States of America

Xingui Liu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Florida Research Foundation Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xingui Liu. Retrieved from https://idiyas.com/inventor/xingui-liu-q5ge7kip

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Xingui Liu

Introduction

Xingui Liu is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of therapeutic agents and methods of treatment. His work focuses on developing compounds that can modulate proliferation activity and treat various diseases and disorders.

Latest Patents

Xingui Liu holds 1 patent for his invention titled "Therapeutic agents and methods of treatment." This patent is directed towards specific compounds, including Formula (I) or its pharmaceutically acceptable salts, hydrates, solvates, or prodrugs. The invention details the mechanism of action of these compounds and outlines methods for their application in treating diseases.

Career Highlights

Xingui Liu is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore innovative solutions in the medical field. His research has the potential to impact the treatment of various health conditions significantly.

Collaborations

Xingui Liu has collaborated with esteemed colleagues, including Guangrong Zheng and Daohong Zhou. These partnerships have fostered a collaborative environment that enhances the research and development of therapeutic agents.

Conclusion

Xingui Liu's contributions to the field of therapeutic agents demonstrate his commitment to innovation and improving healthcare outcomes. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…